enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

3. EPOCH (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/EPOCH_(chemotherapy)

   EPOCH is an intensive chemotherapy regimen intended for treatment of aggressive non-Hodgkin's lymphoma. [1] [2] It is often combined with rituximab. In this case it is called R-EPOCH or EPOCH-R. The R-EPOCH regimen consists of: Rituximab: an anti-CD20 monoclonal antibody, which has the ability to kill B cells, be they normal or malignant;

4. Bendamustine - Wikipedia

   en.wikipedia.org/wiki/Bendamustine

   Common side effects include low blood cell counts, fever, nausea, diarrhea, loss of appetite, cough, and rash. [3] Other severe side effects include allergic reactions and increased risk of infection. [3] Use in pregnancy is known to harm the baby. [3] Bendamustine is in the alkylating agents family of medication. [3]

5. Cancer immunotherapy - Wikipedia

   en.wikipedia.org/wiki/Cancer_immunotherapy

   Common side effects include fever, infection, cough, headache, trouble sleeping, and rash. [144] Other severe side effects include heart failure, allergic reactions, and lung disease. [144] Use during pregnancy may harm the baby. [137] Trastuzumab works by binding to the HER2 receptor and slowing down cell replication. [144]

6. AbbVie Eyes Approval for Imbruvica+Rituxan in First-Line CLL

   www.aol.com/news/abbvie-eyes-approval-imbruvica...

   AbbVie (ABBV) submits a regulatory application with the FDA seeking label expansion of Imbruvica as a first-line treatment for chronic lymphocytic leukemia in combination with Roche's Rituxan.

7. FCM (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/FCM_(chemotherapy)

   FCM, or FMC in the context of chemotherapy is an acronym for a chemotherapy regimen that is used in the treatment of indolent B cell non-Hodgkin's lymphomas. In combination with Rituximab, this regimen is called R-FCM or R-FMC, or FCM-R, FMC-R. The [R]-FCM regimen contains

8. Tumor lysis syndrome - Wikipedia

   en.wikipedia.org/wiki/Tumor_lysis_syndrome

   This occurs most commonly after the treatment of lymphomas and leukemias and in particular when treating non-Hodgkin lymphoma, acute myeloid leukemia, and acute lymphoblastic leukemia. [ 2 ] [ 3 ] This is a potentially fatal complication and people at an increased risk for TLS should be closely monitored while receiving chemotherapy and should ...

9. ICE (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/ICE_(chemotherapy)

   ICE in the context of chemotherapy is an acronym for one of the chemotherapy regimens, used in salvage treatment of relapsed or refractory non-Hodgkin's lymphoma and Hodgkin lymphoma. In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE.